Network with 1,500+ colleagues at the largest protein & antibody engineering event in Europe, which has also been described as "the best biologics technology meeting in Europe."
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
Become a member to continue reading
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
Unlimited access to industry intelligence that can make a difference to your business
A weekly newsletter keeping the most vital information at the front of your thinking
Exclusive invitations to powerful webinars and events featuring high profile experts
Access to deep-dive reports and analysis that reveal exciting new opportunities for business growth and transformation